Aligos Therapeutics ALGS
NASDAQ ALGS
$2.10 +0.12 (+6.06%)
At close: Nov 13, 2026 · 4:00 PM EST

Aligos Therapeutics (ALGS) Net Equity Issued and Repurchased (2019 - 2025)

Updated

Aligos Therapeutics (ALGS) posted Net Equity Issued and Repurchased of $124,000 for Q4 2025, down 10.8% from $139,000 a year earlier.

Analysis

Aligos Therapeutics (ALGS) Net Equity Issued and Repurchased (2019 - 2025) Analysis & Trends

For FY2025, Aligos Therapeutics' Net Equity Issued and Repurchased came in at $304,000, down 30.3% from FY2024.

  • Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -54.6% (FY2020 to FY2025).
  • In prior years, Aligos Therapeutics' Net Equity Issued and Repurchased was $436,000 in FY2024 (-99.0%), $44.98 million in FY2023, $205,000 in FY2022 (-99.7%) and $79.63 million in FY2021 (+407.7%).
  • Quarterly Net Equity Issued and Repurchased has run from a low of -$101.56 million in Q2 2025 to a high of $101.74 million in Q1 2025 over five years.
  • The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q2 2021, with growth of 384.1%; the weakest was Q3 2022, with a decline of 100.0%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -966.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -5.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -283.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Aligos Therapeutics 21.97 Mn -314.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 124,000.00
Jun 30, 2025 -101.56 Mn
Mar 31, 2025 101.74 Mn
Dec 31, 2024 139,000.00
Dec 31, 2023 90,000.00
Jun 30, 2023 461,000.00
Mar 31, 2023 23,000.00
Dec 31, 2022 74,000.00
Sep 30, 2022 9,000.00
Jun 30, 2022 112,000.00
Mar 31, 2022 10,000.00
Dec 31, 2021 720,000.00
Sep 30, 2021 78.60 Mn
Jun 30, 2021 213,000.00
Mar 31, 2021 96,000.00
Dec 31, 2020 445.58 Mn
Sep 30, 2020 135,000.00
Jun 30, 2020 44,000.00
Mar 31, 2020 -404.63 Mn
Dec 31, 2019 317,000.00
API Access

Aligos Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ALGS&period=max&api_key=YOUR_API_KEY